Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average, modest growth trend.
Left:
||||
Year-over-year operating income growth rate
Latest
37.31%
↑ 8518% above average
Average (9y)
0.43%
Historical baseline
Range
High:64.06%
Low:-62.91%
CAGR
+3.7%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 37.31% |
| 2023 | 64.06% |
| 2022 | -10.78% |
| 2021 | 14.46% |
| 2020 | 11.81% |
| 2019 | -15.31% |
| 2018 | -62.91% |
| 2017 | -17.78% |
| 2016 | -43.44% |
| 2015 | 26.91% |